Literature DB >> 25974900

Liver fibrosis in alcoholic liver disease.

Ramon Bataller1, Bin Gao2.   

Abstract

Excessive alcohol consumption causes a wide spectrum of liver disease, ranging from simple steatosis to severe forms of liver injury such as steatohepatitis, liver fibrosis, cirrhosis, and liver cancer. Moreover, alcohol consumption also accelerates liver fibrosis in patients with other types of liver diseases such as viral hepatitis and nonalcoholic fatty liver disease. Virtually all clinical complications of alcoholic liver disease occur in patients with established fibrosis and cirrhosis, thus making fibrosis a key parameter for treatment and prognosis of patients. Here, the authors review diagnosis, management, and antifibrotic therapy of alcoholic liver fibrosis. They discuss both the unique features of alcoholic liver fibrosis and the similarities to liver fibrosis from other etiologies, and review molecular pathogenesis and animal models. Finally, future directions for basic and clinical research on alcoholic liver fibrosis are proposed. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2015        PMID: 25974900     DOI: 10.1055/s-0035-1550054

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  36 in total

1.  Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.

Authors:  Shinji Furuya; Joseph A Cichocki; Kranti Konganti; Kostiantyn Dreval; Takeki Uehara; Yuuki Katou; Hisataka Fukushima; Hiroshi Kono; Igor P Pogribny; Josepmaria Argemi; Ramon Bataller; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

2.  Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood.

Authors:  Akiko Eguchi; Raul G Lazaro; Jiaohong Wang; Jihoon Kim; Davide Povero; Brandon Willliams; Samuel B Ho; Peter Stärkel; Bernd Schnabl; Lucila Ohno-Machado; Hidekazu Tsukamoto; Ariel E Feldstein
Journal:  Hepatology       Date:  2016-11-10       Impact factor: 17.425

3.  Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model.

Authors:  Linghua Yu; Linlin Wang; Huixing Yi; Xiaojun Wu
Journal:  Gut Microbes       Date:  2020-03-13

4.  Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice.

Authors:  Hong Shen; Lin Jiang; Jiandie D Lin; M Bishr Omary; Liangyou Rui
Journal:  J Clin Invest       Date:  2019-03-19       Impact factor: 14.808

Review 5.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

6.  The innate immune receptor TREM-1 promotes liver injury and fibrosis.

Authors:  Anh Thu Nguyen-Lefebvre; Ashwin Ajith; Vera Portik-Dobos; Daniel David Horuzsko; Ali Syed Arbab; Amiran Dzutsev; Ramses Sadek; Giorgio Trinchieri; Anatolij Horuzsko
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

Review 7.  Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver disease.

Authors:  Ning Zhao; Fang-Fang Guo; Ke-Qin Xie; Tao Zeng
Journal:  Cell Mol Life Sci       Date:  2018-06-11       Impact factor: 9.261

8.  Development of Capsular Fibrosis Beneath the Liver Surface in Humans and Mice.

Authors:  Steven Balog; Yuchang Li; Tomohiro Ogawa; Toshio Miki; Takeshi Saito; Samuel W French; Kinji Asahina
Journal:  Hepatology       Date:  2019-08-27       Impact factor: 17.425

Review 9.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

Review 10.  New approaches for fibrosis regression in alcoholic cirrhosis.

Authors:  Wajahat Mehal; Uyen To
Journal:  Hepatol Int       Date:  2016-07-26       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.